Key facts
- This page summarizes Mina Sooch's Form 5 filing for Ocuphire Pharma, Inc. (IRD).
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 14 Feb 2023, 13:05.
Mina Sooch - 31 Dec 2022 Form 5 Insider Report for Ocuphire Pharma, Inc. (IRD)
- Reporting relationship
- President and CEO, Director
- Issuer ticker
- IRD
- Reported as of
- 31 Dec 2022
- Net transaction value
- $0
- SEC form
- 5
- Accepted by SEC
- 14 Feb 2023, 13:05:17 UTC
- Prior SEC filing
- 08 Sep 2022
- Next SEC filing
- 12 Jan 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Emily J. Johns, by Power of Attorney
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Mina Sooch filed Form 5 for Ocuphire Pharma, Inc. (IRD) on 14 Feb 2023.
Change
- Previous filing in this sequence was filed on 08 Sep 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 5 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
OCUP
transaction
Common Stock
Gift
- Transaction value
- $0
- Shares
- -30,000
- Change %
- -7%
- Price
- $0.000000
- Shares after
- 396,045
- Date
- 23 Dec 2022
- Ownership
- Direct
OCUP
transaction
Common Stock
Gift
- Transaction value
- $0
- Shares
- -100,000
- Change %
- -25%
- Price
- $0.000000
- Shares after
- 296,045
- Date
- 27 Dec 2022
- Ownership
- Direct
OCUP
transaction
Common Stock
Gift
- Transaction value
- $0
- Shares
- +50,000
- Change %
- Price
- $0.000000
- Shares after
- 50,000
- Date
- 27 Dec 2022
- Ownership
- Held by Daughter
* marks a reported price that did not pass the local price check.